Emergent Biosolut Stock Total Asset
ER4 Stock | EUR 6.83 0.11 1.59% |
EMERGENT BIOSOLUT fundamentals help investors to digest information that contributes to EMERGENT BIOSOLUT's financial success or failures. It also enables traders to predict the movement of EMERGENT Stock. The fundamental analysis module provides a way to measure EMERGENT BIOSOLUT's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EMERGENT BIOSOLUT stock.
EMERGENT |
EMERGENT BIOSOLUT Company Total Asset Analysis
EMERGENT BIOSOLUT's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current EMERGENT BIOSOLUT Total Asset | 3.17 B |
Most of EMERGENT BIOSOLUT's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EMERGENT BIOSOLUT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition |
Based on the latest financial disclosure, EMERGENT BIOSOLUT has a Total Asset of 3.17 B. This is much higher than that of the sector and significantly higher than that of the Other industry. The total asset for all Germany stocks is notably lower than that of the firm.
EMERGENT Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EMERGENT BIOSOLUT's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EMERGENT BIOSOLUT could also be used in its relative valuation, which is a method of valuing EMERGENT BIOSOLUT by comparing valuation metrics of similar companies.EMERGENT BIOSOLUT is currently under evaluation in total asset category among its peers.
EMERGENT Fundamentals
Current Valuation | 1.34 B | |||
Price To Book | 0.43 X | |||
Price To Sales | 0.42 X | |||
Revenue | 1.12 B | |||
EBITDA | (41.1 M) | |||
Net Income | (223.8 M) | |||
Total Debt | 448.5 M | |||
Cash Flow From Operations | (34.1 M) | |||
Number Of Employees | 18 | |||
Market Capitalization | 1.91 B | |||
Total Asset | 3.17 B | |||
Z Score | 2.4 | |||
Net Asset | 3.17 B |
About EMERGENT BIOSOLUT Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EMERGENT BIOSOLUT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EMERGENT BIOSOLUT using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EMERGENT BIOSOLUT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in EMERGENT Stock
EMERGENT BIOSOLUT financial ratios help investors to determine whether EMERGENT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EMERGENT with respect to the benefits of owning EMERGENT BIOSOLUT security.